2018
DOI: 10.3389/fcell.2018.00097
|View full text |Cite
|
Sign up to set email alerts
|

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression

Abstract: Metastasis is the leading cause of cancer death, tumor progression proceeding through emigration from the primary tumor, gaining access to the circulation, leaving the circulation, settling in distant organs and growing in the foreign environment. The capacity of a tumor to metastasize relies on a small subpopulation of cells in the primary tumor, so called cancer-initiating cells (CIC). CIC are characterized by sets of markers, mostly membrane anchored adhesion molecules, CD44v6 being the most frequently reco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
73
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 99 publications
(87 citation statements)
references
References 366 publications
(465 reference statements)
3
73
0
1
Order By: Relevance
“…Then, we evaluated the level of several stemness-related markers associated with CSC features. FTO knockdown cells displayed enhanced aldehyde dehydrogenase (ALDH) activity, a hallmark of CSC [32] ( Figure 1e ), and increased expression of CD44 and CD44v6 ( Figure 1e ), membrane receptors associated with tumor progression [33] and indispensable for CSC tumor initiation, chemoresistance, and epithelial to mesenchymal transition. CRC1 sh-FTO cells demonstrated a ten-fold increase in the number of CD44+ cells (from 2.1% to 21%) ( Figure 1e ) and CD44v6 isoform expression was doubled ( Figure 1e ).…”
Section: Resultsmentioning
confidence: 99%
“…Then, we evaluated the level of several stemness-related markers associated with CSC features. FTO knockdown cells displayed enhanced aldehyde dehydrogenase (ALDH) activity, a hallmark of CSC [32] ( Figure 1e ), and increased expression of CD44 and CD44v6 ( Figure 1e ), membrane receptors associated with tumor progression [33] and indispensable for CSC tumor initiation, chemoresistance, and epithelial to mesenchymal transition. CRC1 sh-FTO cells demonstrated a ten-fold increase in the number of CD44+ cells (from 2.1% to 21%) ( Figure 1e ) and CD44v6 isoform expression was doubled ( Figure 1e ).…”
Section: Resultsmentioning
confidence: 99%
“…Finally, PaCIC biomarkers are enriched in TEX (84)(85)(86). This is important as CIC drive the metastatic process (87)(88)(89)(90), where Tspan8 (86,91) and associated α6β4 (92-94), CD44v6 (95,96), and linked cMET 1 (96,97), CD184/CXCR4 1 that can associate with Tspan8 and CD44v6 (98-100), cldn7 (84,101,102), and associated EpCAM 1 (84,103,104), LGR5/GPR49 1 (105,106) and CD133/PROM1 1 (107,108) are engaged in distinct steps of tumor progression.…”
Section: Exosome Compositionmentioning
confidence: 99%
“…It supports extravasation by selectin binding to EC, allowing crawling toward EC-EC gaps. It assists tumor stroma formation and premetastatic niche preparation by HA, matrix-remodeling enzyme, cytokine, and chemokine provision (91,327). Recruiting miRNA into ILV expands the range of TEX activities (322).…”
Section: Cd44v6 and Cd44v6-associated Receptor Tyrosine Kinasesmentioning
confidence: 99%
“…Особенностью некоторых типов эпителиальных клеток и злокачественных опухолей эпителиального происхождения является преимущественная экспрессия альтернативно сплайсированного варианта белка изоформы CD44v (Williams et al, 2013). Локализация CD44v на клеточной мембране -важнейший фактор миграции и инвазии опухолевых клеток (Wang et al, 2018).…”
Section: физиологическая генетика / Physiological Geneticsunclassified